Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Research
Multiple Introductions and Cross-Sector Transmission of Salmonella enterica Serovar Infantis Carrying blaCTX-M-65 Gene, South Korea, 2022–2024
Table
Antimicrobial resistance patterns of 65 isolates from a study of multiple introductions and cross-sector transmission of Salmonella enterica serovar Infantis carrying blaCTX-M-65 gene, South Korea, 2022–2024
| Antimicrobial resistance pattern | No. (%) isolates |
|---|---|
| β-lactams–tetracyclines | 1 (1.5) |
| β-lactams–quinolones–tetracyclines | 2 (3.1) |
| β-lactams–tetracyclines–amphenicols | 1 (1.5) |
| β-lactams–quinolones-tetracyclines–amphenicols | 2 (3.1) |
| Aminoglycosides–β-lactams-quinolones–tetracyclines | 1 (1.5) |
| β-lactams–quinolones–tetracyclines–amphenicols–folate pathway inhibitors | 7 (10.8) |
| Aminoglycosides–β-lactams–quinolones–tetracyclines–folate pathway inhibitors | 1 (1.5) |
| Aminoglycosides–β-lactams–quinolones–tetracyclines–amphenicols | 7 (10.8) |
| Aminoglycosides–β-lactams–quinolones–tetracyclines–amphenicols–folate pathway inhibitors | 43 (66.2) |
| Aminoglycosides–β-lactams–quinolones–polymyxins–tetracyclines–amphenicols–folate pathway inhibitors | 1 (1.5) |
1These first authors contributed equally to this article.
2These authors contributed equally to this article.
Page created: August 20, 2026
Page updated: September 16, 2026
Page reviewed: September 16, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.